A comprehensive view of prescription drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
BIOGEN INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
April 24, 2024
by SEC Edgar Filings
|
Cofepris issues favorable opinion for Pfizer's oral COVID-19 treatment, enabling potential nationwide distribution in Mexico; the Commission is expected to make a final ruling in the coming weeks
Published:
April 24, 2024
by CE Noticias Financieras (Latin America)
|
Morgan Stanley: Tobacco industry has reason to fret about GLP-1 drugs like Ozempic; survey finds 40% smoked cigarettes at least weekly before starting drug, and number fell to 24% after treatment, while weekly e-cigarette usage fell from 30% to 16%
Published:
April 24, 2024
by Gizmodo
|
Roche reports group sales increase by 2% year-over-year due to the success of newer medicines and diagnostics, independent of COVID-19 products; the surge was offset by the strengthening of the Swiss franc and a decline in COVID-19 test demand
Published:
April 24, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Study shows that withdrawing aspirin and keeping high-risk heart patients on ticagrelor a month after a percutaneous coronary intervention improves outcomes and reduces bleeding by over half; the findings may change worldwide standard of care guidelines
Published:
April 23, 2024
by Insurance Daily News
|
Ask us about our Health Care Sector market view